Hussman Strategic Advisors’s Rigel Pharmaceuticals RIGL Stock Holding History

Hussman Strategic Advisors’s Portfolio RIGL Stock Details RIGL Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	$2.25M	Buy
2023 Q2	–	Sell
2023 Q1	$206K	Hold
2022 Q4	$234K	Hold
2022 Q3	$184K	Hold
2022 Q2	$176K	Hold
2022 Q1	$466K	Hold
2021 Q4	$413K	Buy